mRNA 1083
Alternative Names: COVID+Flu vaccine - Moderna Therapeutics; mCOMBRIAX; mRNA-1083; mRNA-1083.1; mRNA-1083.2; mRNA-1083.3; Seasonal flu + COVID combination vaccine - Moderna TherapeuticsLatest Information Update: 14 Aug 2026
At a glance
- Originator Moderna Therapeutics
- Class COVID-19 vaccines; Influenza virus vaccines; RNA vaccines; Viral vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered COVID 2019 infections; Influenza virus infections